ZAMBROTTA, GIOVANNI PAOLO MARIA
ZAMBROTTA, GIOVANNI PAOLO MARIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape
2024 Fontana, D; Zambrotta, G; Scannella, A; Piazza, R; Gambacorti-Passerini, C
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas
2023 Rindone, G; Aroldi, A; Bossi, E; Verga, L; Zambrotta, G; Tarantino, S; Piazza, R; Mussolin, L; Chiarle, R; Gambacorti-Passerini, C
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study
2021 Cavalca, F; Renso, R; Zambrotta, G; Gambacorti Passerini, C; Elli, E
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine
2020 Fontana, D; Mauri, M; Renso, R; Docci, M; Crespiatico, I; Rost, L; Jang, M; Niro, A; D'Aliberti, D; Massimino, L; Bertagna, M; Zambrotta, G; Bossi, M; Citterio, S; Crescenzi, B; Fanelli, F; Cassina, V; Corti, R; Salerno, D; Nardo, L; Chinello, C; Mantegazza, F; Mecucci, C; Magni, F; Cavaletti, G; Bruheim, P; Rea, D; Larsen, S; Piazza, R; Gambacorti-Passerini, C
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine
2020 Fontana, D; Mauri, M; Renso, R; Docci, M; Crespiatico, I; Rost, L; Jang, M; Niro, A; D'Aliberti, D; Massimino, L; Bertagna, M; Zambrotta, G; Bossi, M; Citterio, S; Crescenzi, B; Fanelli, F; Cassina, V; Corti, R; Salerno, D; Nardo, L; Chinello, C; Mantegazza, F; Mecucci, C; Magni, F; Cavaletti, G; Bruheim, P; Rea, D; Larsen, S; Gambacorti-Passerini, C; Piazza, R
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION
2018 Fontana, D; Mauri, M; Niro, A; Massimino, L; Bertagna, M; Zambrotta, G; Bossi, M; Citterio, S; Crescenzi, B; Signore, G; Piazza, V; Mecucci, C; Cavaletti, G; Rea, D; Gambacorti-Passerini, C; Piazza, R
ETNK1 mutations increase mitochondrial activity and promote DNA damage through ROS production
2018 Fontana, D; Mauri, M; Niro, A; Massimino, L; Bertagna, M; Zambrotta, G; Bossi, M; Citterio, S; Crescenzi, B; Signore, G; Piazza, V; Fanelli, F; Mecucci, C; Cavaletti, G; Rea, D; Gambacorti Passerini, C; Piazza, R